Cellectar Biosciences, Inc. Series A Warrants
CLRBZ
CLRBZ was delisted on the 16th of April, 2021.
1 hedge funds and large institutions have $104K invested in Cellectar Biosciences, Inc. Series A Warrants in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
35% less capital invested
Capital invested by funds: $161K → $104K (-$57K)
67% less funds holding
Funds holding: 3 → 1 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11.8K |
| 2 |
VF
Virtu Financial
New York
|
-$10K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $104K | -$11.8K | -19,000 | -8% |
|
|
VF
2
Virtu Financial
New York
| – | -$10K | -15,596 | Closed |
|
|
3
Wells Fargo
San Francisco,
California
| – | -$3K | -5,000 | Closed |
|
CLRBZ Hedge Fund Activity: Q4 2017 in Review
1 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) for Q4 2017, worth a combined $104K — down 35% from $161K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CLRBZ and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, cutting an estimated $11.8K.
- 1 institutional investor held Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) as of Q4 2017, down from 3 in Q3 2017.
- Funds reported $104K of Cellectar Biosciences, Inc. Series A Warrants stock for Q4 2017, down 35% quarter-over-quarter.
- 0 funds opened new Cellectar Biosciences, Inc. Series A Warrants positions in Q4 2017 and 2 closed out, a net change of -2 holders.
- The largest Cellectar Biosciences, Inc. Series A Warrants seller in Q4 2017 was Susquehanna International Group, an estimated $11.8K sold.
Based on aggregated 13F filings for Q4 2017.